UBS lowered the firm’s price target on Colgate-Palmolive (CL) to $92 from $99 and keeps a Buy rating on the shares. The firm sees another “dynamic” earnings season for U.S. consumer staples, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL: